APA (7th ed.) Citation

Rudenko, L., Desheva, J., Korovkin, S., Mironov, A., Rekstin, A., Grigorieva, E., . . . Katlinsky, A. (2008). Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I–II clinical trials). Influenza and other respiratory viruses, 2(6), 203-209. https://doi.org/10.1111/j.1750-2659.2008.00064.x

Chicago Style (17th ed.) Citation

Rudenko, Larisa, Julia Desheva, Sergey Korovkin, Alexander Mironov, Andrey Rekstin, Elena Grigorieva, Svetlana Donina, Alexandra Gambaryan, and Anton Katlinsky. "Safety and Immunogenicity of Live Attenuated Influenza Reassortant H5 Vaccine (phase I–II Clinical Trials)." Influenza and Other Respiratory Viruses 2, no. 6 (2008): 203-209. https://doi.org/10.1111/j.1750-2659.2008.00064.x.

MLA (9th ed.) Citation

Rudenko, Larisa, et al. "Safety and Immunogenicity of Live Attenuated Influenza Reassortant H5 Vaccine (phase I–II Clinical Trials)." Influenza and Other Respiratory Viruses, vol. 2, no. 6, 2008, pp. 203-209, https://doi.org/10.1111/j.1750-2659.2008.00064.x.